Groundbreaking, Alpharmaxim

Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson's Disease and identifies clear opportunities to improve treatment options

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

Alpharmaxim England United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/groundbreaking-pan-european-study-by-alpharmaxim-and-aston-university-harnesses-behavioural-science-to-uncover-factors-influencing-prescribing-practice-in-parkinsons-disease-and-identifies-clear-opportunities-to-improve-treatment-302496785.html

en | boerse | 67945517 |